Published in Addiction on November 17, 2009
Dynamic vaccine blocks relapse to compulsive intake of heroin. Proc Natl Acad Sci U S A (2013) 1.24
Opioid addiction and abuse in primary care practice: a comparison of methadone and buprenorphine as treatment options. J Natl Med Assoc (2012) 1.01
Long term outcomes of pharmacological treatments for opioid dependence: does methadone still lead the pack? Br J Clin Pharmacol (2014) 0.89
Normalizing effect of heroin maintenance treatment on stress-induced brain connectivity. Brain (2014) 0.79
Increased functional connectivity in the resting-state basal ganglia network after acute heroin substitution. Transl Psychiatry (2015) 0.77
Commentary on Blanken et al. (2010): long-term heroin-assisted treatment-some more questions and answers. Addiction (2010) 0.75
Cessation of Injecting and Preceding Drug Use Patterns Among a Prospective Cohort of Street-Involved Youth. J Adolesc Health (2017) 0.75
Medical prescription of heroin to treatment resistant heroin addicts: two randomised controlled trials. BMJ (2003) 5.72
Neurocognitive functions in pathological gambling: a comparison with alcohol dependence, Tourette syndrome and normal controls. Addiction (2006) 2.23
Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study. Addiction (2014) 2.16
Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene. Biol Psychiatry (2012) 2.10
Heroin-assisted treatment as a response to the public health problem of opiate dependence. Eur J Public Health (2002) 1.89
Should there be both categorical and dimensional criteria for the substance use disorders in DSM-V? Addiction (2006) 1.88
Decision making in pathological gambling: a comparison between pathological gamblers, alcohol dependents, persons with Tourette syndrome, and normal controls. Brain Res Cogn Brain Res (2005) 1.88
Reduced-risk drinking as a viable treatment goal in problematic alcohol use and alcohol dependence. J Psychopharmacol (2013) 1.79
Predictors of the 2-year recurrence and persistence of alcohol dependence. Addiction (2012) 1.78
Prediction of relapse to frequent heroin use and the role of methadone prescription: an analysis of the Amsterdam Cohort Study among drug users. Drug Alcohol Depend (2005) 1.69
Alcohol use disorders and the course of depressive and anxiety disorders. Br J Psychiatry (2012) 1.66
Why gamblers fail to win: a review of cognitive and neuroimaging findings in pathological gambling. Neurosci Biobehav Rev (2009) 1.66
Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study. Arch Gen Psychiatry (2007) 1.62
Attentional bias predicts heroin relapse following treatment. Addiction (2006) 1.61
Effects of modafinil on neural correlates of response inhibition in alcohol-dependent patients. Biol Psychiatry (2012) 1.58
What can the Swiss and Dutch trials tell us about the potential risks associated with heroin prescribing? Drug Alcohol Rev (2003) 1.57
Response perseveration and ventral prefrontal sensitivity to reward and punishment in male problem gamblers and smokers. Neuropsychopharmacology (2008) 1.56
SSRI treatment of borderline personality disorder: a randomized, placebo-controlled clinical trial for female patients with borderline personality disorder. Am J Psychiatry (2002) 1.54
Suicide risk in placebo-controlled trials of treatment for acute manic episode and prevention of manic-depressive episode. Am J Psychiatry (2005) 1.52
Modafinil modulates resting-state functional network connectivity and cognitive control in alcohol-dependent patients. Biol Psychiatry (2013) 1.49
Are scratchcards addictive? The prevalence of pathological scratchcard gambling among adult scratchcard buyers in the Netherlands. Addiction (2003) 1.46
Deep brain stimulation restores frontostriatal network activity in obsessive-compulsive disorder. Nat Neurosci (2013) 1.45
Screening for Posttraumatic Stress Disorder: an evaluation of two self-report scales among crime victims. Psychol Assess (2003) 1.44
Grey matter alterations associated with cannabis use: results of a VBM study in heavy cannabis users and healthy controls. Neuroimage (2011) 1.41
Heroin-assisted treatment (HAT) a decade later: a brief update on science and politics. J Urban Health (2007) 1.40
Alcohol use disorders in EU countries and Norway: an overview of the epidemiology. Eur Neuropsychopharmacol (2005) 1.39
Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis. Drug Alcohol Depend (2011) 1.36
Instability of the ecstasy market and a new kid on the block: mephedrone. J Psychopharmacol (2010) 1.36
The relationship between impulsive choice and impulsive action: a cross-species translational study. PLoS One (2012) 1.33
Initial validation of two opiate craving questionnaires the obsessive compulsive drug use scale and the desires for drug questionnaire. Addict Behav (2002) 1.33
Brain activation patterns associated with cue reactivity and craving in abstinent problem gamblers, heavy smokers and healthy controls: an fMRI study. Addict Biol (2010) 1.30
Properties of the Hopkins Symptom Checklist-25 (HSCL-25) and the Self-Reporting Questionnaire (SRQ-20) as screening instruments used in primary care in Afghanistan. Soc Psychiatry Psychiatr Epidemiol (2007) 1.29
A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence. Eur Neuropsychopharmacol (2013) 1.27
The COMT val158met polymorphism and brain morphometry in healthy young adults. Neurosci Lett (2006) 1.25
Cost utility analysis of co-prescribed heroin compared with methadone maintenance treatment in heroin addicts in two randomised trials. BMJ (2005) 1.23
Striatal dopamine transporter availability associated with polymorphisms in the dopamine transporter gene SLC6A3. J Nucl Med (2008) 1.23
Distorted expectancy coding in problem gambling: is the addictive in the anticipation? Biol Psychiatry (2012) 1.23
Cortisol moderates the relationship between testosterone and aggression in delinquent male adolescents. Biol Psychiatry (2006) 1.21
Pharmacokinetics and pharmacodynamics of high doses of pharmaceutically prepared heroin, by intravenous or by inhalation route in opioid-dependent patients. Basic Clin Pharmacol Toxicol (2006) 1.21
Dialectical Behavior Therapy of borderline patients with and without substance use problems. Implementation and long-term effects. Addict Behav (2002) 1.20
A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction. Drug Alcohol Depend (2004) 1.20
Sustained efficacy of dialectical behaviour therapy for borderline personality disorder. Behav Res Ther (2005) 1.19
Psychiatric disorders in detained male adolescents: a systematic literature review. Can J Psychiatry (2010) 1.16
Comorbid psychopathology in adolescents and young adults treated for substance use disorders: a review. Eur Child Adolesc Psychiatry (2006) 1.16
Psychophysiological determinants and concomitants of deficient decision making in pathological gamblers. Drug Alcohol Depend (2006) 1.15
Ranking the harm of alcohol, tobacco and illicit drugs for the individual and the population. Eur Addict Res (2010) 1.15
Intrauterine cannabis exposure affects fetal growth trajectories: the Generation R Study. J Am Acad Child Adolesc Psychiatry (2009) 1.14
Neurobiological substrates of cue-elicited craving and anhedonia in recently abstinent opioid-dependent males. Drug Alcohol Depend (2008) 1.14
Predictors of acamprosate efficacy: results from a pooled analysis of seven European trials including 1485 alcohol-dependent patients. Psychopharmacology (Berl) (2004) 1.13
Measuring craving: an attempt to connect subjective craving with cue reactivity. Alcohol Clin Exp Res (2006) 1.13
Hyperresponsiveness of hypothalamic-pituitary-adrenal axis to combined dexamethasone/corticotropin-releasing hormone challenge in female borderline personality disorder subjects with a history of sustained childhood abuse. Biol Psychiatry (2002) 1.13
Neurophysiological evidence for abnormal cognitive processing of drug cues in heroin dependence. Psychopharmacology (Berl) (2003) 1.11
The quantitative analysis of heroin, methadone and their metabolites and the simultaneous detection of cocaine, acetylcodeine and their metabolites in human plasma by high-performance liquid chromatography coupled with tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 1.11
An increase in overdose mortality during the first 2 weeks after entering or re-entering methadone treatment in Amsterdam. Addiction (2002) 1.09
Psychiatric disorders in a representative sample of incarcerated boys in the Netherlands. J Am Acad Child Adolesc Psychiatry (2004) 1.09
Decision-making deficits in alcohol-dependent patients with and without comorbid personality disorder. Alcohol Clin Exp Res (2006) 1.08
Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users. Brain (2008) 1.08
N-acetylcysteine normalizes glutamate levels in cocaine-dependent patients: a randomized crossover magnetic resonance spectroscopy study. Neuropsychopharmacology (2012) 1.07
The association between neighborhood disorder, social cohesion and hazardous alcohol use: a national multilevel study. Drug Alcohol Depend (2012) 1.07
The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: Opioid dependence. World J Biol Psychiatry (2011) 1.06
Striatal dopamine D2 receptor binding and dopamine release during cue-elicited craving in recently abstinent opiate-dependent males. Eur Neuropsychopharmacol (2008) 1.06
Similar hyporesponsiveness of the dorsomedial prefrontal cortex in problem gamblers and heavy smokers during an inhibitory control task. Drug Alcohol Depend (2011) 1.06
Neurobiological substrate of smoking-related attentional bias. Neuroimage (2010) 1.06
Endogenous cannabinoids are not involved in cocaine reinforcement and development of cocaine-induced behavioural sensitization. Eur Neuropsychopharmacol (2005) 1.04
Comorbidity and risk indicators for alcohol use disorders among persons with anxiety and/or depressive disorders: findings from the Netherlands Study of Depression and Anxiety (NESDA). J Affect Disord (2011) 1.04
Treatment seeking adults with autism or ADHD and co-morbid substance use disorder: prevalence, risk factors and functional disability. Drug Alcohol Depend (2009) 1.04
Effects of non-invasive neurostimulation on craving: a meta-analysis. Neurosci Biobehav Rev (2013) 1.04
Predicting the transition from frequent cannabis use to cannabis dependence: a three-year prospective study. Drug Alcohol Depend (2013) 1.03
Response inhibition during cue reactivity in problem gamblers: an fMRI study. PLoS One (2012) 1.03
'Legal highs' an inappropriate term for 'Novel Psychoactive Drugs' in drug prevention and scientific debate. Int J Drug Policy (2012) 1.02
Validity of the EQ-5D as a generic health outcome instrument in a heroin-dependent population. Drug Alcohol Depend (2005) 1.01
The three year course of alcohol use disorders in the general population: DSM-IV, ICD-10 and the Craving Withdrawal Model. Addiction (2006) 1.01
Mental health differences between frequent cannabis users with and without dependence and the general population. Addiction (2013) 1.00
Cue exposure therapy for the treatment of opiate addiction: results of a randomized controlled clinical trial. Psychother Psychosom (2007) 0.99
Pharmacokinetics and pharmacokinetic variability of heroin and its metabolites: review of the literature. Curr Clin Pharmacol (2006) 0.99
Brain imaging studies in pathological gambling. Curr Psychiatry Rep (2010) 0.99
The Client Satisfaction Questionnaire: psychometric properties in a Dutch addict population. Eur Addict Res (2005) 0.99
A systematic review of the effectiveness of naltrexone in the maintenance treatment of opioid and alcohol dependence. Eur Neuropsychopharmacol (2005) 0.99
Neonatal development of projections from the basolateral amygdala to prefrontal, striatal, and thalamic structures in the rat. J Comp Neurol (2002) 0.98
A common variant in DRD3 receptor is associated with autism spectrum disorder. Biol Psychiatry (2008) 0.98
Neural responses associated with cue-reactivity in frequent cannabis users. Addict Biol (2012) 0.98
Personality characteristics of adults with autism spectrum disorders or attention deficit hyperactivity disorder with and without substance use disorders. J Nerv Ment Dis (2009) 0.98
A prospective cohort study on sustained effects of low-dose ecstasy use on the brain in new ecstasy users. Neuropsychopharmacology (2006) 0.96
Individual differences in decision making and reward processing predict changes in cannabis use: a prospective functional magnetic resonance imaging study. Addict Biol (2012) 0.96
Predicting the effect of naltrexone and acamprosate in alcohol-dependent patients using genetic indicators. Addict Biol (2009) 0.96
Drug dependence and the endogenous opioid system. Eur Neuropsychopharmacol (2003) 0.96
The role of dopamine in human addiction: from reward to motivated attention. Eur J Pharmacol (2005) 0.96
The high harm score of alcohol. Time for drug policy to be revisited? J Psychopharmacol (2013) 0.95
Matching of treatment-resistant heroin-dependent patients to medical prescription of heroin or oral methadone treatment: results from two randomized controlled trials. Addiction (2005) 0.95